Toxicology Drug Screening Market Report 2026

Toxicology Drug Screening Market Overview

• Toxicology Drug Screening market size has reached to $21.44 billion in 2025 • Expected to grow to $33.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Rising Drug Abuse Driving Growth Of The Market Due To Increasing Need For Early Detection And Monitoring • Market Trend: Innovative Forensic Toxicology Screening Solutions Driving Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Toxicology Drug Screening Market?

Toxicology drug screening is a process used to detect the presence of drugs, chemicals, or their metabolites in biological samples such as urine, blood, saliva, or hair. It is a type of medical test commonly used to identify both legal and illegal substances in a person's system. The main purpose is to identify and measure drug exposure in an individual, which can serve various needs depending on the context. The main types of toxicology drug screening are monitoring and logging, security, storage and continuous integration or continuous deployment, management and orchestration, networking and data management services, and others. Monitoring and logging in toxicology drug screening involve continuously tracking and recording data from tests and processes. It includes various test types such as acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, organ-specific toxicity, and technologies such as high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening. It includes various applications such as immunotoxicity, systemic toxicity, developmental and reproductive toxicity (DART), endocrine disruption, and others, catering to diverse end users including hospitals, clinics, contract research organizations (CROs), pharmaceutical companies, and workplace testing facilities.

What Is The Toxicology Drug Screening Market Growth Forecast?

The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $33.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to development of ai-driven predictive toxicology tools, integration of genomics and transcriptomics in screening, growth of contract research organizations (cros), rising demand for real-time drug monitoring systems, implementation of cloud-based and secure data management platforms. Major trends in the forecast period include growing adoption of high-throughput screening technologies, integration of lims and laboratory information systems, rising use of predictive and ai-powered toxicology platforms, expansion of workplace drug screening programs, enhanced focus on data security and compliance standards.

Global Toxicology Drug Screening Market Segmentation

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems 2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity 3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening 4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications 5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities Subsegments: 1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays 2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests 3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits 4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits 5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips 6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

What Is The Driver Of The Toxicology Drug Screening Market?

The rising prevalence of drug abuse is expected to propel the growth of the toxicology drug screening market going forward. Drug abuse is the harmful or excessive use of drugs for non-medical purposes that negatively impacts a person’s health and life. The prevalence of drug abuse is rising due to increased stress and mental health challenges, which lead many individuals to misuse substances as a way to cope. Toxicology drug screening is useful for drug abuse because it helps detect the presence of drugs or their metabolites in a person’s body, enabling early identification, diagnosis, and monitoring of substance misuse or overdose. For instance, in August 2024, according to the National Records of Scotland (NRS), a Scotland-based government department, Scotland recorded 1,172 drug misuse deaths in 2023, marking a 12% rise (121 additional deaths) compared to 2022. Therefore, the rising prevalence of drug abuse is driving the toxicology drug screening industry.

Key Players In The Global Toxicology Drug Screening Market

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Global Toxicology Drug Screening Market Trends and Insights

Major companies operating in the toxicology drug screening market are focusing on introducing innovative solutions, such as the 3D liver microphysiological system, which allows for culturing highly biomimetic human liver microtissues with organized cell arrangements and active metabolic function. 3D liver microphysiological system (MPS) is an advanced in vitro platform designed to replicate the physiological microenvironment of the human liver more accurately than traditional cell culture methods and typically involves culturing multiple types of human liver cells. For instance, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in the development of organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit, an all-in-one laboratory kit developed for in vitro profiling of human drug-induced liver injury and a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it also offers effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing time to adoption.

What Are Latest Mergers And Acquisitions In The Toxicology Drug Screening Market?

In September 2024, Scantox Group, a Denmark-based preclinical contract research organization that provides toxicology testing, acquired Gentronix for an undisclosed amount. With this acquisition, Scantox Group aims to expand its early toxicity testing capabilities by integrating Gentronix's expertise in genetic toxicology and predictive safety assessment, enhancing its service offerings for pharmaceutical and chemical industries. Gentronix is a UK-based preclinical contract research organization that provides toxicology services, including drug screening.

Regional Insights

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Toxicology Drug Screening Market?

The toxicology drug screening market consists of revenues earned by entities by providing services, such as pre-employment drug testing, sports drug testing, confirmatory testing, addiction treatment monitoring, and pain management monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Toxicology Drug Screening Market Report 2026?

The toxicology drug screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the toxicology drug screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.